Brain samples from AD patients with a late Braak stage (IV–VI) and their respective controls (Supplementary Table S2) as well as PBMCs from a cohort of AD and MCI individuals and their age-matched controls (Table 2) were used to determine CD4 mRNA levels and its association with cognitive status. Here, CD4 is linked to Alzheimer disease.